Ups and downs in pharma industry due to crucial supply chain hiccups

Ups and downs in pharma industry due to crucial supply chain hiccups

After months of challenges and faults in the global ingredient supply chain, peaks and valleys are the landscape for Vietnamese drug giants in their first-half performance, and several factors remain that could damage their operational prospects in the months to come.
Top pharma groups to rethink strategies after sluggish 2018

Top pharma groups to rethink strategies after sluggish 2018

After a tough 12 months, with Vietnamese pharmaceutical giants continuing to report poor business performance in the first quarter of 2019, new solutions are being sought in order to hold firm amid increasingly mounting competition from international rivals. Bich Thuy reports.